198 related articles for article (PubMed ID: 9573230)
1. Particle size determinants in the human immunodeficiency virus type 1 Gag protein.
Garnier L; Ratner L; Rovinski B; Cao SX; Wills JW
J Virol; 1998 Jun; 72(6):4667-77. PubMed ID: 9573230
[TBL] [Abstract][Full Text] [Related]
2. Identification of retroviral late domains as determinants of particle size.
Garnier L; Parent LJ; Rovinski B; Cao SX; Wills JW
J Virol; 1999 Mar; 73(3):2309-20. PubMed ID: 9971814
[TBL] [Abstract][Full Text] [Related]
3. Genetic determinants of Rous sarcoma virus particle size.
Krishna NK; Campbell S; Vogt VM; Wills JW
J Virol; 1998 Jan; 72(1):564-77. PubMed ID: 9420260
[TBL] [Abstract][Full Text] [Related]
4. N-Terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles.
Gross I; Hohenberg H; Huckhagel C; Kräusslich HG
J Virol; 1998 Jun; 72(6):4798-810. PubMed ID: 9573245
[TBL] [Abstract][Full Text] [Related]
5. Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins.
Bennett RP; Nelle TD; Wills JW
J Virol; 1993 Nov; 67(11):6487-98. PubMed ID: 8411352
[TBL] [Abstract][Full Text] [Related]
6. The role of nucleocapsid of HIV-1 in virus assembly.
Dawson L; Yu XF
Virology; 1998 Nov; 251(1):141-57. PubMed ID: 9813210
[TBL] [Abstract][Full Text] [Related]
7. Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release.
Wang CT; Lai HY; Li JJ
J Virol; 1998 Oct; 72(10):7950-9. PubMed ID: 9733833
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the spacer peptide and adjoining sequences in Rous sarcoma virus Gag lead to tubular budding.
Keller PW; Johnson MC; Vogt VM
J Virol; 2008 Jul; 82(14):6788-97. PubMed ID: 18448521
[TBL] [Abstract][Full Text] [Related]
9. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
Fitzon T; Leschonsky B; Bieler K; Paulus C; Schröder J; Wolf H; Wagner R
Virology; 2000 Mar; 268(2):294-307. PubMed ID: 10704338
[TBL] [Abstract][Full Text] [Related]
10. Critical Role of the Human T-Cell Leukemia Virus Type 1 Capsid N-Terminal Domain for Gag-Gag Interactions and Virus Particle Assembly.
Martin JL; Mendonça LM; Marusinec R; Zuczek J; Angert I; Blower RJ; Mueller JD; Perilla JR; Zhang W; Mansky LM
J Virol; 2018 Jul; 92(14):. PubMed ID: 29695435
[TBL] [Abstract][Full Text] [Related]
11. Effects of nucleocapsid mutations on human immunodeficiency virus assembly and RNA encapsidation.
Zhang Y; Barklis E
J Virol; 1997 Sep; 71(9):6765-76. PubMed ID: 9261401
[TBL] [Abstract][Full Text] [Related]
12. Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging.
Luo K; Liu B; Xiao Z; Yu Y; Yu X; Gorelick R; Yu XF
J Virol; 2004 Nov; 78(21):11841-52. PubMed ID: 15479826
[TBL] [Abstract][Full Text] [Related]
13. Dominant Negative MA-CA Fusion Protein Is Incorporated into HIV-1 Cores and Inhibits Nuclear Entry of Viral Preintegration Complexes.
Anderson-Daniels J; Singh PK; Sowd GA; Li W; Engelman AN; Aiken C
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413124
[TBL] [Abstract][Full Text] [Related]
14. Assembly and release of human immunodeficiency virus type 1 Gag proteins containing tandem repeats of the matrix protein coding sequences in the matrix domain.
Wang CT; Chen SS; Chiang CC
Virology; 2000 Dec; 278(1):289-98. PubMed ID: 11112503
[TBL] [Abstract][Full Text] [Related]
15. Intracellular localization of human immunodeficiency virus type 1 Gag and GagPol products and virus particle release: relationship with the Gag-to-GagPol ratio.
Haraguchi H; Sudo S; Noda T; Momose F; Kawaoka Y; Morikawa Y
Microbiol Immunol; 2010 Dec; 54(12):734-46. PubMed ID: 21091985
[TBL] [Abstract][Full Text] [Related]
16. The retroviral capsid domain dictates virion size, morphology, and coassembly of gag into virus-like particles.
Ako-Adjei D; Johnson MC; Vogt VM
J Virol; 2005 Nov; 79(21):13463-72. PubMed ID: 16227267
[TBL] [Abstract][Full Text] [Related]
17. Role of Mason-Pfizer monkey virus CA-NC spacer peptide-like domain in assembly of immature particles.
Strohalmová-Bohmová K; Spiwok V; Lepšík M; Hadravová R; Křížová I; Ulbrich P; Pichová I; Bednárová L; Ruml T; Rumlová M
J Virol; 2014 Dec; 88(24):14148-60. PubMed ID: 25275119
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic differences between nucleic acid chaperone activities of the Gag proteins of Rous sarcoma virus and human immunodeficiency virus type 1 are attributed to the MA domain.
Rye-McCurdy TD; Nadaraia-Hoke S; Gudleski-O'Regan N; Flanagan JM; Parent LJ; Musier-Forsyth K
J Virol; 2014 Jul; 88(14):7852-61. PubMed ID: 24789780
[TBL] [Abstract][Full Text] [Related]
19. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1.
Campbell S; Vogt VM
J Virol; 1995 Oct; 69(10):6487-97. PubMed ID: 7666550
[TBL] [Abstract][Full Text] [Related]
20. Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein.
Puffer BA; Parent LJ; Wills JW; Montelaro RC
J Virol; 1997 Sep; 71(9):6541-6. PubMed ID: 9261374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
